Literature DB >> 8825912

Effect of thalidomide on the inflammatory response in cerebrospinal fluid in experimental bacterial meningitis.

M H Burroughs1, L Tsenova-Berkova, K Sokol, J Ossig, E Tuomanen, G Kaplan.   

Abstract

In experimental bacterial meningitis in rabbits, the inflammatory process is largely mediated by cytokines such as IL-1 and TNF-alpha. Since thalidomide has been shown to inhibit TNF-alpha production, experiments were carried out to determine whether the drug can modulate the inflammatory response to either lysates of H. influenzae (gram negative) or heat killed S. pneumoniae (gram positive) in rabbits. The introduction of a lysate of H. influenzae into the CSF of rabbits causes a very acute inflammatory response, as indicated by a rapid increase in TNF-alpha levels in the CSF and a concomitantly rapid leukocytosis. In contrast, the introduction of heat killed S. pneumoniae, induces a more indolent inflammatory response which also wanes more slowly. Thalidomide treatment reduces TNF-alpha production in both experimental systems, but has a greater effect on the more indolent gram positive inflammatory response in which peak TNF-alpha levels in the CSF are reduced by > 50%. Also, a sustained inhibition of leukocytosis is observed in the inflammatory response to heat-killed gram positive bacteria. In meningeal inflammation induced by the Gram negative lysate, treatment with thalidomide results in only a 29% inhibition of TNF-alpha release into the CSF. In contrast to the drug effect on TNF-alpha, thalidomide treatment does not significantly affect IL-1 levels in these models of rabbit bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8825912     DOI: 10.1016/s0882-4010(95)90299-6

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  9 in total

Review 1.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.

Authors:  C Ostergaard; R V Yieng-Kow; T Benfield; N Frimodt-Møller; F Espersen; J D Lundgren
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis.

Authors:  Liana Tsenova; Bande Mangaliso; George Muller; Yong Chen; Victoria H Freedman; David Stirling; Gilla Kaplan
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.

Authors:  L G Corral; G W Muller; A L Moreira; Y Chen; M Wu; D Stirling; G Kaplan
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

6.  Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system.

Authors:  L Tsenova; A Bergtold; V H Freedman; R A Young; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

7.  Systemic Injection of Thalidomide Prevent and Attenuate Neuropathic Pain and Alleviate Neuroinflammatory Response in the Spinal Dorsal Horn.

Authors:  Hao Xu; Sha-Jie Dang; Yuan-Yuan Cui; Zhen-Yu Wu; Jun-Feng Zhang; Xiao-Peng Mei; Yu-Peng Feng; Yun-Qing Li
Journal:  J Pain Res       Date:  2019-11-29       Impact factor: 3.133

8.  Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid.

Authors:  Z Cao; W R Joseph; W L Browne; K G Mountjoy; B D Palmer; B C Baguley; L M Ching
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

9.  An improved protocol to establish experimental tuberculous meningitis in the rabbit.

Authors:  Paul O'Brien; Christopher Vinnard; Selvakumar Subbian
Journal:  MethodsX       Date:  2020-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.